Summary & Overview

HCPCS G8876: Documentation for Not Performing Minimally Invasive Breast Biopsy

HCPCS Level II code G8876 captures clinician documentation explaining why a minimally invasive needle biopsy was not performed to establish a preoperative breast cancer diagnosis. This code matters nationally because it records medically appropriate exceptions to recommended biopsy pathways, supports accurate clinical records, and can affect preoperative planning and claims adjudication. Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical settings where it is reported, and the implications for documentation and claims processing. The publication outlines common scenarios captured by the code — for example, lesions that are not amenable to needle biopsy due to location or visualization limits, patient-specific factors that preclude needle biopsy, or alternative procedures such as excisional biopsy or prophylactic mastectomy. It also summarizes which payers recognize the code and what clinicians and billing staff should expect when documenting reasons for omission of minimally invasive biopsy. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG8876HCPCS Level IIbreast biopsydiagnostic documentationpreoperative planningneedle biopsy exceptionssurgical oncologyimaging-guided biopsy

Billing Code Overview

HCPCS Level II code G8876 documents the clinician's reason(s) for not performing a minimally invasive biopsy to diagnose breast cancer preoperatively. Examples in the descriptor include situations such as a lesion too close to the skin, implant, or chest wall; inability to adequately visualize the lesion for needle biopsy; patient factors that prevent needle biopsy (for example, weight or breast thickness); duct excision without an imaging abnormality; prophylactic mastectomy; or an excisional biopsy performed by another physician.

Service type: Diagnostic documentation related to breast biopsy decision-making — reporting that a minimally invasive needle biopsy was not performed and why.

Typical site of service: Breast imaging, surgical clinic, or hospital outpatient setting where diagnostic evaluation and preoperative decision-making occur.

Clinical & Coding Specifications

Clinical Context

A typical patient is a woman presenting with a suspicious breast lesion identified on screening or diagnostic mammography, ultrasound, or MRI. Preoperative planning determines whether a minimally invasive percutaneous needle biopsy (core needle biopsy or image-guided vacuum-assisted biopsy) can safely and adequately obtain tissue to confirm malignancy prior to definitive surgical treatment. Documentation of reason(s) for not performing a minimally invasive biopsy (billing code G8876) is used when the surgeon or diagnosing clinician proceeds to excisional biopsy or definitive surgery without a preceding needle biopsy because of specific technical, anatomic, imaging, or patient-related constraints.

Common real-world scenario: A patient with a palpable breast mass and prior imaging showing a lesion immediately subdermal and adherent to a reconstructive implant. The multidisciplinary team determines that percutaneous needle biopsy would risk implant rupture, provide inadequate tissue sampling, or be technically unsafe. The surgeon documents the rationale (e.g., lesion too close to skin, implant in place, lesion not well visualized on imaging, patient body habitus prevents safe needle access, duct excision for nipple discharge without imaging abnormality, prophylactic mastectomy, or prior excisional biopsy performed by another physician). The documentation is included in the preoperative record and billed with G8876 to indicate reasons a minimally invasive biopsy was not obtained prior to surgery. Typical sites of service include outpatient surgical centers, hospital outpatient departments, ambulatory care clinics, and inpatient surgical units when immediate excision is undertaken.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required is substantially greater than typical for the service due to complexity of documentation or operative decision-making related to inability to perform needle biopsy.
`23`	Unusual anesthesia	Use when general anesthesia is required for an otherwise minor procedure because needle biopsy cannot be performed safely in the awake patient.
`52`	Reduced services	Use when a planned diagnostic procedure was partially performed or a less extensive procedure was completed because needle biopsy was not feasible.
`53`	Discontinued procedure	Use when attempt at image-guided biopsy was started but aborted due to technical/anatomic barriers, and documentation supports discontinuation.
`54`	Surgical care only	Use when the surgeon performs the excision but another clinician provides pre/postoperative care; relevant when excisional biopsy replaces needle biopsy.
`55`	Postoperative management only	Use when another clinician performed the operation and the reporting provider is responsible only for postoperative follow-up.
`56`	Preoperative management only	Use when the reporting clinician furnished only the preoperative evaluation documenting reasons for not doing a needle biopsy.
`62`	Two surgeons	Use when two surgeons are required due to complexity of excision that replaced an infeasible needle biopsy (e.g., reconstructive considerations, implant management).
`AS`	Physician assistant services	Use to indicate services rendered by a certified assistant at surgery when roles affect documentation of why needle biopsy was not performed.
`53`	Discontinued procedure	(Note: `53` may be applied in image-guided biopsy attempts aborted for safety/anatomic reasons.)

Taxonomy Code	Specialty	Notes
207Q00000X	General Surgery	Surgeons performing diagnostic excisions and breast oncologic surgery.
207RH0000X	Breast Surgery	Surgeons with a focus on breast procedures and preoperative decision-making.
207LP2900X	Surgical Oncology	Surgeons managing cancer diagnosis and deciding when excision is necessary without needle biopsy.
207V00000X	Plastic Surgery	Surgeons involved when reconstructive implants or cosmetic history affect biopsy feasibility.
207L00000X	Otolaryngology–Head & Neck Surgery	Occasionally involved when lesions near the chest wall or skin/more complex anatomic considerations are present.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N63`	Unspecified lump in breast	Common presenting sign prompting biopsy; may be excised when needle biopsy is not feasible.
`R92.8`	Other abnormal and inconclusive findings on diagnostic imaging of breast	Imaging-detected lesions not well visualized for percutaneous biopsy.
`C50.911`	Malignant neoplasm of unspecified site of right female breast	Malignancy suspected where preoperative needle biopsy could not be safely obtained.
`C50.912`	Malignant neoplasm of unspecified site of left female breast	As above for left-sided disease.
`N64.4`	Mastodynia (cyclical)	Symptoms that may prompt duct excision when imaging is negative and needle biopsy is not indicated.
`N64.89`	Other specified disorders of breast	Miscellaneous breast conditions leading to surgical management without needle biopsy.
`Z90.12`	Acquired absence of both breasts and nipples	Relevant when prior reconstructive history or implants affect biopsy feasibility.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`19120`	Excision of cyst, fibroadenoma, or other benign or malignant tumor, open; single lesion	Often used when an excisional biopsy or definitive tumor removal is performed instead of a minimally invasive needle biopsy.
`19301`	Mastectomy, partial (e.g., lumpectomy, tylectomy, quadrantectomy, segmental resection)	Used when definitive breast-conserving surgery is performed without prior needle biopsy due to documented contraindication.
`19125`	Excision of breast lesion identified by preoperative placement of radiological marker, open; single lesion	Used when lesion localization and open excision are performed because percutaneous biopsy was not feasible.
`19081`	Biopsy, breast, with placement of breast localization device(s) when performed; preoperative placement	Performed when localization for excision is required because needle biopsy could not be obtained.
`76942`	Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device)	May be performed during attempted image-guided biopsy; if aborted, documentation supports `G8876`.